A novel methodology for enhanced and consistent heterologous expression of unmodified human cytochrome P450 1B1 (CYP1B1)

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Faiq, Muneeb A ^a,b,c   Ali, Mashook ^b   Dada, Tanuj ^a   Dada, Rima ^c   Saluja, Daman ^b  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b UNIVERSITY OF DELHI   (India)

^c ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; CYTOCHROME P450 1B1; ISOPROPYL THIOGALACTOSIDE; THIAMINE; CULTURE MEDIUM; CYP1B1 PROTEIN, HUMAN; MEMBRANE PROTEIN; RECOMBINANT PROTEIN;

ARTICLE; BACTERIAL STRAIN; CULTURE MEDIUM; ESCHERICHIA COLI; EXPRESSION VECTOR; HETEROLOGOUS EXPRESSION; PROTEIN EXPRESSION; ROTATION; TEMPERATURE; BIOSYNTHESIS; GENE EXPRESSION REGULATION; GENETICS; GLAUCOMA; HUMAN; MUTATION; PATHOLOGY;

CULTURE MEDIA; CYTOCHROME P-450 CYP1B1; ESCHERICHIA COLI; GENE EXPRESSION REGULATION; GLAUCOMA; HUMANS; MEMBRANE PROTEINS; MUTATION; RECOMBINANT PROTEINS;

EID: 84908053036     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0110473     Document Type: Article

References (56)

1. Sutter TR, Tang YM, Hayes CL, Wo YYP, Jabs EW, et al. (1994) Complete cDNA sequence of a human dioxin-inducible mRNA identifies a new gene subfamily of cytochrome P450 that maps to chromosome 2. J Biol Chem 269:13092-99.
2. Murray GI, Melvin WT, Greenlee WF, Burke MD (2001) Regulation, function and tissue-specific expression of Cytochrome P450 CYP1B1. Annu Rev Pharmacol Toxicol 41: 297-316.
3. Tang YM, Wo YYP, Stewart J, Hawkins AL, Griffins CA, et al. (1996) Isolation and characterization of human CYP1B1 gene. J Biol Chem 271: 28324-30.
4. Murray G, Taylor M, McFadyen M, McKay JA, Greelnee WF, et al. (1997) Tumor-specific expression of cytochrome P450 CYP1B1. Cancer Res 57: 3026-3031.
5. McFadyen M, Murray G (2005) Cytochrome P450 1B1: a novel anticancer therapeutic target. Future Oncology 1: 259-263.
6. Maecker B, Sherr D, Vonderheide R, von Bergwelt-Baildon MS, Hirano N, et al. (2003) The shared tumor-associated antigen cytochrome P450 1B1 is recognized by specific cytotoxic T cells. Blood 102: 3287-3294.
7. McFadyen M, Breeman S, Payne S, Stirk C, Miller ID, et al. (1999) Immunohistochemical localization of cytochrome P450 CYP1B1 in breast cancer with monoclonal antibodies specific for CYP1B1. J Histochem Cytochem 47: 1457-1464.
8. Oyama T, Morita M, Isse T, Kaqawa N, Nakata S, et al. (2005) Immunohistochemical evaluation of cytochrome P450 (CYP) and p53 in breast cancer. Front Biosci 10: 1156-1161.
9. McFadyen M, Cruickshank ME, Miller ID, McLeod HL, Melvin WT, et al. (2001) Cytochrome P450 CYP1B1 over-expression in primary and metastatic ovarian cancer. Br J Cancer 85: 242-246.
10. Gibson P, Gill JH, Khan PA, Seargent JM, Martin SW, et al. (2003) Cytochrome P450 1B1 (CYP1B1) is overexpressed in human colon adenosarcomas relative to normal colon: implications for drug development. Mol Cancer Ther 2: 527-534.
11. Carnell DM, Smith RE, Daley FM, Barber PR, Hoskin PJ, et al. (2004) Target validation of cytochrome P450 CYP1B1 in prostate carcinoma with protein expression in assoaited hyperplastic and premalignant tissue. Int J Radiat Oncol Biol Phys 58: 500-509.
12. Stoilov I, Rezaie T, Jansson I, Schenkman JB, Sarfarazi M (2004) Expression of cytochrome P4501b1 (Cyp1b1) during early murine development. Mol Vis 10:629-36.
13. Bejjani BA, Xu L, Armstrong D, Lupski JR, Reneker LW (2002) Expression patterns of cytochrome P4501B1 (Cyp1b1) in FVB/N mouse eyes. Exp Eye Res 75(3):249-57.
14. Doshi M, Marcus C, Bejjani BA, Edward DP (2006) Immunolocalization of CYP1B1 in normal, human, fetal and adult eyes. Exp Eye Res 82(1): 24-32.
15. Chavarria-Soley G, Sticht H, Aklillu E, Ingelman-Sundberg M, Pasutto F, et al. (2008) Mutations in CYP1B1 cause primary congenital glaucoma by reduction of either activity or abundance of the enzyme. Hum Mutat 29(9): 1147-53.
16. Kaur K, Mandal AK, Chakrabarti S (2011) Primary Congenital Glaucoma and the Involvement of CYP1B1. Middle East Arf J Ophthalmol 18(1):7-16.
17. Sarfarazi M, Stoilov I (2000) Molecular genetics of primary congenital glaucoma. Eye 14: 422-428.
18. Tanwar M, Dada T, Sihota R, Dada R (2009) Identification of four novel cytochrome P4501B1 mutations (p.I94X, p.H279D, p.Q340H, and p.K433K) in primary congenital glaucoma patients. Mol Vis 15: 2926-37
19. Tanwar M, Dada T, Sihota R, Das TK, Yadav U, et al. (2009) Mutation spectrum of CYP1B1 in North Indian congenital glaucoma patients. Mol Vis 15:1200-9.
20. Faiq M, Mohanty K, Dada R, Dada T (2013) Molecular Diagnostics and Genetic Counseling in Primary Congenital Glaucoma. J Curr Glaucoma Prac 7:25-35.
21. Faiq M, Sharma R, Dada R, Mohanty K, Saluja D, et al. (2013) Genetic, Biochemical and Clinical Insights into Primary Congenital Glaucoma J Curr Glaucoma Prac 7: 66-84.
22. Jansson I, Stoilov I, Sarfarazi M, Schenkman JB (2000). Enhanced expression of CYP1B1 in Escherichia coli. Toxicol 144: 211-291.
23. Elizabeth MJG, Guo Z, Martin MV, Christopher MJ, Guengerich FP (1995) Expression of cytochrome P4502D6 in Escherichia coli, Purification, and Spectral and Catalytic Characterization. Archive Biochem and Biophys 319(2):540-550.
24. Li N, Zhou Y, Du L, Wei M, Chen X (2011) Overview of cytochrome P450 1B1 mutations in patients with primary congenital glaucoma. Exp Eye Res 93: 572-579
25. Orawan K, Sunutcha S (2012) Strategies for production of active proteins in bacterial expression system. Asian Pacific Journal of Tropical Biomedicine. 159-162
26. Rai M, Padh H (2001) Expression system for production of heterologous proteins. Curr Sci 80(9): 1121-28.
27. Low C, Jegerschold C, Kovermann M, Moberg P, Nordlund P (2012) Optimisation of overexpression in E. coli and biophysical Characterization of Human Membrane Protein Synaptogyrin 1. PlosOne. 7(6): e38244.
28. Ma P, Varela F, Magoch M, Silva AR, Rosario AL, et al. (2013) An efficient strategy of small-scale screening and production of archeal membrane transport protein in Escerichia coli. PlosOne 8(10): e76913.
29. Sandhu P, Guo Z, Baba T, Martin M, Tukey R, et al. (1994). Expression of modified human cytochrome P450 1A2 in Escherichia coli: Stabilization, purification, spectral characterization and catalytic activities the enzyme. Arch Biochem Biophys 309: 168-177.
30. Shimada T, Wunsch RM, Hanna IH, Sutter TR, Guengerich FP, et al. (1998) Recombinant human cytochrome P450 1B1 expression in Escherichia coli. Arch Biochem Biophys 357(1): 111-120.
31. Sivashanmugam A, Murray V, Cui C, Zhang Y, Wang J, et al. (2009) Practical Protocol for production of very high yields of recombinant proteins using Escherichia coli. Prot Sci 18: 936-948.
32. Towbin H, Staehelin T, Gordon J (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76: 4350-4354.
33. Schenkman JB, Jansson I (1998) Spectral analysis of cytochrome P450. In: Methods in Molecular biology, Vol. 107. Humana Press. Totowa, NJ, pp. 25-33.
34. Freigassner M, Pichler H, Glieder A (2009) Tuning microbial hosts for membrane protein production. Microb Cell Fact 8: 69.
35. Pavlov MY, Watts RE, Tan Z, Cornish VW, Ehrenberg M, et al. (2009) Slow peptide bond formation by proline and other N-alkylamino acids in translation. Proc Natl Acad Sci USA 106: 50-54.
36. Welch M, Villalobos A, Gustafsson C, Minshul J (2011) Designing genes for successful protein expression. Synthetic Biology: Computer Aided Design and DNA Assembly Ed: Chris Voigt. pp. 43-65.
37. Allert M, Cox JC, Hellinga HW (2010) Multifactorial determinants of protein expression in prokaryotic open reading frames. J Mol Biol 402: 905-918.
38. Chen GT, Inouye M (1994) Role of the AGA/AGG codons, the rarest codons in global gene expression in Escherichia coli. Genes Dev 8: 2641-2652.
39. Eyre-Walker A, Bulmer M (1993) Reduced synonymous substitution rate at the start of enterobacterial genes. Nucleic Acids Res. 21: 4599-4603.
40. Gonzalez de Valdivia EI, Isaksson LA (2004) A codon window in mRNA downstream of the initiation codon where NGG codons give strongly reduced gene expression in Escherichia coli. Nucleic Acids Res 32: 5198-5205.
41. Kudla G, Murray AW, Tollervey D, Plotkin JB (2009) Coding-sequence determinants of gene expression in Escherichia coli. Science 324: 255-258.
42. Stenström CM, Isaksson LA (2002) Influences on translation initiation and early elongation by the messenger RNA region flanking the initiation codon at the 30 side. Gene 288: 1-8.
43. Stenström CM, Holmgren E, Isaksson LA (2001) Cooperative effects by the initiation codon and its flanking regions on translation initiation. Gene 273: 259-265.
44. Stenström CM, Jin H, Major LL, Tate WP, Isaksson LA (2001) Codon bias at the 30 -side of the initiation codon is correlated with translation initiation efficiency in Escherichia coli. Gene 263: 273-284.
45. Tuller T, Waldman YY, Kupiec M, Ruppin E (2010) Translation efficiency is determined by both codon bias and folding energy. Proc Natl Acad Sci USA 107: 3645-3650.
46. Panicker SG, Reddy ABM, Mandal AK, Ahmed N, Nagarajaram HA, et al. (2002) Identification of Novel Mutations Causing Familial Primary Congenital Glaucoma in Indian Pedigrees. Invest. Ophthalmol. Vis. Sci 43: 51358-1366.
47. Stoilov I, Akarsu AN, Sarfarazi M (1997) Identification of three different truncating mutations in cytochrome P4501B1 (CYP1B1) as the principal cause of primary congenital glaucoma (buphthalmos) in families linked to the GLC3A locus on chromosome 2p21. Hum Mol Genet 6: 641-647.
48. Bejjani BA, Lewis RA, Tomey KF, Anderson KL, Dueker DK, et al. (1998) Mutations in CYP1B1, the gene for cytochrome P4501B1, are the predominant cause of primary congenital glaucoma in Saudi Arabia. Am J Hum Genet 62:325-333.
49. Bejjani BA, Stockton DW, Lewis RA, Tomey KF, Dueker DK, et al. (2000) Multiple CYP1B1 mutations and incomplete penetrance in an inbred population segregating primary congenital glaucoma suggest frequent de novo events and a dominant modifier locus. Hum Mol Genet 9: 367-374.
50. Corisdeo S, Wang B (2004) Functional expression and display in Escherichia coli: study of vector designs and culture conditions. Prot. Exp. Purif 34: 270-279.
51. Sahdev K, Khattar SK, Saini KS (2008) Production of active eukaryotic proteins thorugh bacterial expression systems: a review of the existing biotechnology strategies. Mol Cell Biochem 307: 249-264.
52. Peti W, Page R (2007) Strategies to maximize heterologous protein expression in Escherichia coli with minimal cost. Protein Expr Purif 51: 1-10.
53. Arditti RR, Scaife JG, Beckwith JR (1968) The nature of mutants in the lac promoter region. J Mol Biol 38: 421-426.
54. Schlegel S, Klepsch M, Gialama D, Wickstrom D, Slotboom DJ, et al. (2010) Revolutionizing membrane protein overexpression in bacteria. Micorbial Biotechnology, 3(4): 403-411.
55. Saida F (2007). Overview on the expression of toxic gene products in Escherichia coli. Current Protoc. Protein Sci. Ch7. Unit: 5.9.
56. Caspeta L, Flores N, Perez NO, Bolivar F, Ramirez OT (2009) The effect on heating rate on Escherichia coli metabolism, physiological stress, transcriptional response, and production of temperature-induced recombinant protein: a scale-down study. Biotechnol Bioeng 102: 468-482.